Vault-13

BIOHAVEN PHARMACTL HLDG CO L BHVN

COM · Common Stock · CUSIP G11196105 · ISIN VGG111961055

3 institutional holders +1 vs Q1 2024
725,240725.2k shares reported held*
$25.2mreported value*
1 new 1 added 0 reduced 0 sold out net bought ≈ $7.6m (+220.1k shares)

* Summed across managers. Shares that two managers' reports both contain – a subsidiary's holdings that its parent's report includes too, or a sub-adviser's in its client's – are counted once. Holder counts are more reliable. Implied quarter-end price ≈ $34.71.

Trends to Q2 2024

Institutional holders

Managers reporting a position, each quarter

0100200300Q3 22: 240Q4 22: 7Q1 23: 2Q2 23: 1Q3 23: 1Q4 23: 2Q1 24: 2Q2 24: 33Q3 22Q1 23Q3 23Q1 24Q2 24
Numbers
QuarterHolders
Q3 2022240
Q4 20227
Q1 20232
Q2 20231
Q3 20231
Q4 20232
Q1 20242
Q2 20243

Buyers vs sellers

Managers adding to or starting a position, vs cutting or selling out

Bought or addedCut or sold out
4000400Q4 22: 2 bought or addedQ4 22: 231 cut or sold outQ4 22Q1 23: 0 bought or addedQ1 23: 6 cut or sold outQ2 23: 0 bought or addedQ2 23: 1 cut or sold outQ2 23Q3 23: 1 bought or addedQ3 23: 0 cut or sold outQ4 23: 1 bought or addedQ4 23: 0 cut or sold outQ4 23Q1 24: 0 bought or addedQ1 24: 0 cut or sold outQ2 24: 2 bought or addedQ2 24: 0 cut or sold outQ2 24
Numbers
QuarterBought or addedCut or sold out
Q4 20222231
Q1 202306
Q2 202301
Q3 202310
Q4 202310
Q1 202400
Q2 202420

Biggest buyers

Biggest sellers

None

Insider purchases and sales in Q2 2024

Shares bought or sold by the company's own officers, directors and 10% owners, in the open market or privately, as they reported to the SEC on Form 4 (due within two business days of the trade). Grants, option exercises, shares withheld for tax and gifts aren't included.

Officers and directors buying vs selling

Number of people, by quarter (10% owners not included)

BuyingSelling
505Q3 22: 0 buyingQ3 22: 0 sellingQ4 22: 5 buyingQ4 22: 0 sellingQ4 22Q1 23: 0 buyingQ1 23: 0 sellingQ2 23: 0 buyingQ2 23: 0 sellingQ2 23Q3 23: 1 buyingQ3 23: 0 sellingQ4 23: 4 buyingQ4 23: 1 sellingQ4 23Q1 24: 0 buyingQ1 24: 0 sellingQ2 24: 4 buyingQ2 24: 0 sellingQ2 24
Numbers
QuarterBuyingBoughtSellingSoldSold under a plan
Q3 20220—0——
Q4 20225$61.6m0——
Q1 20230—0——
Q2 20230—0——
Q3 20231$2.9m0——
Q4 20234$20.9m1$459.7k—
Q1 20240—0——
Q2 20244$14.5m0——
DateInsiderTradeSharesPrice ValueTheir holding
2024-06-17 Car Bruce Chief Scientific Officer · By IRA Bought 30,000 $33.58 $1.0m30.0k shares new
2024-05-30 CHILDS JOHN W Director · By John W Childs 2013 Revocable Trust Bought 28,000 $35.58 $996.2k28.0k shares +1%
2024-05-13 CHILDS JOHN W Director · By John W Childs 2013 Revocable Trust Bought 28,500 $35.17 $1.0m28.5k shares +1%
2024-05-13 Bailey Gregory Director Bought 15,000 $34.19 $512.8k15.0k shares +1%
2024-04-24 Bailey Gregory Director Bought 25,503 $39.18 $999.2k25.5k shares +2%
2024-04-22 Coric Vlad Chief Executive Officer, director Bought 121,951 $41.00 $5.0m122.0k shares +7%
2024-04-22 CHILDS JOHN W Director · By 2013 Charitable Remainder Trust Bought 73,170 $41.00 $3.0m73.2k shares new
2024-04-22 Bailey Gregory Director Bought 48,780 $41.00 $2.0m48.8k shares +3%

Their holding: how much the trade added to or took from the insider's holding (direct, or the trust or fund named). The same trade is sometimes reported by more than one insider, such as a fund and the director who represents it; totals count it once. A value is left blank where the reported price is far from the market price (usually a typo).

Holders, Q2 2024

#ManagerLocationShares Value% of their portfolioChangeShares change
1 Knoll Capital Management, LLC 16.62% of their portfolio MIAMI, FL 710,422710.4k $24.7m $24.7m 16.62% Added +220.0k +220,000
2 Birchview Capital, LP 0.24% of their portfolio BURLINGTON, VT 14,73014.7k $511.3k $511.3k 0.24% Unchanged
3 Itau Unibanco Holding S.A. 0.00% of their portfolio SAO PAULO, D5 8888 $3.1k $3.1k 0.00% New